MA26617A1 - 5,6-dichloro-2-(isopropylamino)-1-(béta-l-ribofuranosyl)-1h-benzimidazole de forme iv - Google Patents

5,6-dichloro-2-(isopropylamino)-1-(béta-l-ribofuranosyl)-1h-benzimidazole de forme iv

Info

Publication number
MA26617A1
MA26617A1 MA25520A MA25520A MA26617A1 MA 26617 A1 MA26617 A1 MA 26617A1 MA 25520 A MA25520 A MA 25520A MA 25520 A MA25520 A MA 25520A MA 26617 A1 MA26617 A1 MA 26617A1
Authority
MA
Morocco
Prior art keywords
ribofuranosyl
isopropylamino
dichloro
beta
benzimidazole form
Prior art date
Application number
MA25520A
Other languages
English (en)
Inventor
Howard Carter Barry
Hodgson Anne
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26617A1 publication Critical patent/MA26617A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA25520A 1998-04-07 1999-04-05 5,6-dichloro-2-(isopropylamino)-1-(béta-l-ribofuranosyl)-1h-benzimidazole de forme iv MA26617A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807355.4A GB9807355D0 (en) 1998-04-07 1998-04-07 Antiviral compound

Publications (1)

Publication Number Publication Date
MA26617A1 true MA26617A1 (fr) 2004-12-20

Family

ID=10829933

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25520A MA26617A1 (fr) 1998-04-07 1999-04-05 5,6-dichloro-2-(isopropylamino)-1-(béta-l-ribofuranosyl)-1h-benzimidazole de forme iv

Country Status (39)

Country Link
US (1) US6482939B1 (fr)
EP (1) EP1070078B1 (fr)
JP (1) JP2002510702A (fr)
KR (1) KR100573635B1 (fr)
CN (1) CN1222534C (fr)
AP (1) AP2000001946A0 (fr)
AR (1) AR014973A1 (fr)
AT (1) ATE231517T1 (fr)
AU (1) AU753527B2 (fr)
BG (1) BG104909A (fr)
BR (2) BRPI9909471B8 (fr)
CA (1) CA2327495C (fr)
CO (1) CO5011057A1 (fr)
DE (1) DE69905025T2 (fr)
DK (1) DK1070078T3 (fr)
EA (1) EA002953B1 (fr)
EE (1) EE04121B1 (fr)
EG (1) EG24597A (fr)
ES (1) ES2191429T3 (fr)
GB (1) GB9807355D0 (fr)
GE (1) GEP20022840B (fr)
HR (1) HRP20000670B1 (fr)
HU (1) HUP0101549A3 (fr)
ID (1) ID26573A (fr)
IL (2) IL138559A0 (fr)
IS (1) IS5634A (fr)
MA (1) MA26617A1 (fr)
NO (1) NO316896B1 (fr)
NZ (1) NZ507012A (fr)
OA (1) OA11534A (fr)
PE (1) PE20000356A1 (fr)
PL (1) PL194752B1 (fr)
PT (1) PT1070078E (fr)
SI (1) SI1070078T1 (fr)
SK (1) SK283735B6 (fr)
TR (1) TR200002847T2 (fr)
WO (1) WO1999051617A2 (fr)
YU (1) YU58600A (fr)
ZA (1) ZA200005197B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
WO2009112470A2 (fr) * 2008-03-12 2009-09-17 Janssen Pharmaceutica Nv Combinaisons de composés d'hydroxypyrion et de composés de l'argent
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8541391B2 (en) * 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
WO2023105483A1 (fr) * 2021-12-10 2023-06-15 Assembly Biosciences, Inc. Formes cristallines d'un composé 5-aminopyrazole utiles pour le traitement du vhb
CN119136799A (zh) 2022-10-12 2024-12-13 武田药品工业株式会社 制备马立巴韦的方法
AU2024280278A1 (en) 2023-05-31 2025-11-27 Takeda Pharmaceutical Company Limited Maribavir compositions and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1994008456A1 (fr) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Benzimidazoles polysubstitues utilises comme agents antiviraux
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB2319961A (en) 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound

Also Published As

Publication number Publication date
CN1222534C (zh) 2005-10-12
DE69905025D1 (de) 2003-02-27
EE200000585A (et) 2002-04-15
EA002953B1 (ru) 2002-12-26
CA2327495C (fr) 2009-01-20
CN1304413A (zh) 2001-07-18
SI1070078T1 (en) 2003-08-31
HUP0101549A3 (en) 2003-07-28
IS5634A (is) 2000-09-22
US6482939B1 (en) 2002-11-19
AP2000001946A0 (en) 2000-12-31
EP1070078B1 (fr) 2003-01-22
ID26573A (id) 2001-01-18
BRPI9909471B1 (pt) 2018-11-21
CA2327495A1 (fr) 1999-10-14
WO1999051617A2 (fr) 1999-10-14
ATE231517T1 (de) 2003-02-15
DK1070078T3 (da) 2003-05-19
BG104909A (bg) 2001-06-29
SK14822000A3 (sk) 2001-07-10
EE04121B1 (et) 2003-08-15
TR200002847T2 (tr) 2001-01-22
KR100573635B1 (ko) 2006-04-26
EG24597A (en) 2009-12-14
GB9807355D0 (en) 1998-06-03
HRP20000670A2 (en) 2000-12-31
PT1070078E (pt) 2003-06-30
BR9909471A (pt) 2000-12-19
YU58600A (sh) 2003-04-30
PL194752B1 (pl) 2007-07-31
HUP0101549A2 (hu) 2001-10-28
NO20005003D0 (no) 2000-10-04
HK1032060A1 (en) 2001-07-06
CO5011057A1 (es) 2001-02-28
DE69905025T2 (de) 2003-10-16
NZ507012A (en) 2003-06-30
HRP20000670B1 (en) 2004-04-30
PL343712A1 (en) 2001-08-27
NO20005003L (no) 2000-12-06
AR014973A1 (es) 2001-04-11
AU753527B2 (en) 2002-10-17
WO1999051617A3 (fr) 1999-12-09
EA200000909A1 (ru) 2001-06-25
ZA200005197B (en) 2001-09-27
EP1070078A2 (fr) 2001-01-24
IL138559A0 (en) 2001-10-31
IL138559A (en) 2006-12-31
NO316896B1 (no) 2004-06-14
GEP20022840B (en) 2002-11-25
SK283735B6 (sk) 2003-12-02
BRPI9909471B8 (pt) 2021-05-25
PE20000356A1 (es) 2000-04-26
OA11534A (en) 2004-05-06
AU3703899A (en) 1999-10-25
ES2191429T3 (es) 2003-09-01
KR20010074473A (ko) 2001-08-04
JP2002510702A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
CU23053A3 (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
BR9915534B1 (pt) 1-piridil substituìdo)-1,2,4-triazóis inseticidas.
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
DE69826127D1 (de) 2-substituierte 4,5-diarylimidazole
EE200200275A (et) Immunosupressantidena kasutatavad 2,4-diaminopürimidiiniühendid
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
NO985335D0 (no) 2,4-Diaminopyrimidinderivater
MA26617A1 (fr) 5,6-dichloro-2-(isopropylamino)-1-(béta-l-ribofuranosyl)-1h-benzimidazole de forme iv
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ATE234839T1 (de) 4,5-azolo-oxindole
ID23752A (id) Katalis untuk pengkloran-oksi etilena pada 1,2-dikloroetana
NO20004807L (no) 3´,3´-N-bis-substituerte makrolid LHRH antagonister
PT1129079E (pt) Derivados de triazina 2,4-dissubstituidos
EP1156040A4 (fr) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
DE69815072D1 (de) Substituierte 2,4-diaminopyrimidine
ES1041880Y (es) Puya de picador.
ES1039737Y (es) Acumulador termico perfeccionado.
ES1041028Y (es) Formulario de correspondencia.
ES1040277Y (es) Agrupador de perchas perfeccionado.
ES1043757Y (es) Camison perfeccionado.
IT1304449B1 (it) Cravatta di abbigliamento.
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.